|
1
|
Kumar-Sinha C, Tomlins SA and Chinnaiyan
AM: Recurrent gene fusions in prostate cancer. Nature Rev.
8:497–511. 2008.PubMed/NCBI
|
|
2
|
Hsu DS, Kim MK, Balakumaran BS, et al:
Immune signatures predict prognosis in localized cancer. Cancer
Invest. 28:765–773. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin WW and Karin M: A cytokine-mediated
link between innate immunity, inflammation, and cancer. J Clin
Invest. 117:1175–1183. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shimura S, Yang G, Ebara S, Wheeler TM,
Frolov A and Thompson TC: Reduced infiltration of tumor-associated
macrophages in human prostate cancer: association with cancer
progression. Cancer Res. 60:5857–5861. 2000.PubMed/NCBI
|
|
5
|
Vesalainen S, Lipponen P, Talja M and
Syrjanen K: Histological grade, perineural infiltration,
tumour-infiltrating lymphocytes and apoptosis as determinants of
long-term prognosis in prostatic adenocarcinoma. Eur J Cancer.
30A:1797–1803. 1994. View Article : Google Scholar
|
|
6
|
Rajarubendra N, Lawrentschuk N, Bolton DM,
Klotz L and Davis ID: Prostate cancer immunology - an update for
Urologists. BJU Int. 107:1046–1051. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shaikhibrahim ZLA, Ellinger J, Rogenhofer
S, Buettner R and Wernert N: Identification of immunity-related
genes in prostate cancer and potential role of the ETS family of
transcription factors in their regulation. Int J Mol Med.
28:799–807. 2011.PubMed/NCBI
|
|
8
|
Tomlins SA, Rhodes DR, Perner S, et al:
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in
prostate cancer. Science. 310:644–648. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gallant S and Gilkeson G: ETS
transcription factors and regulation of immunity. Arch Immunol Ther
Exp (Warsz). 54:149–163. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Alipov G, Nakayama T, Ito M, et al:
Overexpression of Ets-1 proto-oncogene in latent and clinical
prostatic carcinomas. Histopathology. 46:202–208. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rothhammer T, Hahne JC, Florin A, et al:
The Ets-1 transcription factor is involved in the development and
invasion of malignant melanoma. Cell Mol Life Sci. 61:118–128.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hahne JC, Okuducu AF, Kaminski A, Florin
A, Soncin F and Wernert N: Ets-1 expression promotes epithelial
cell transformation by inducing migration, invasion and anchorage-
independent growth. Oncogene. 24:5384–5388. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sahin A, Vercamer C, Kaminski A, et al:
Dominant-negative inhibition of Ets 1 suppresses tumor growth,
invasion and migration in rat C6 glioma cells and reveals
differentially expressed Ets 1 target genes. Int J Oncol.
34:377–389. 2009.
|
|
14
|
Shaikhibrahim Z, Langer B, Lindstrot A, et
al: Ets-1 is implicated in the regulation of androgen co-regulator
FHL2 and reveals specificity for migration, but not invasion, of
PC3 prostate cancer cells. Oncol Rep. 25:1125–1129. 2011.PubMed/NCBI
|
|
15
|
Shaikhibrahim Z, Lindstrot A, Langer B,
Buettner R and Wernert N: Comprehensive gene expression microarray
analysis of Ets-1 blockade in PC3 prostate cancer cells and
correlations with prostate cancer tissues: Insights into genes
involved in the metastatic cascade. Int J Mol Med. 27:811–819.
2011.
|
|
16
|
Chen CA and Okayama H: Calcium
phosphate-mediated gene transfer: a highly efficient transfection
system for stably transforming cells with plasmid DNA.
BioTechniques. 6:632–638. 1988.PubMed/NCBI
|
|
17
|
Liu AY, Roudier MP and True LD:
Heterogeneity in primary and metastatic prostate cancer as defined
by cell surface CD profile. Am J Pathol. 165:1543–1556. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Milde T, Oehme I, Korshunov A, et al:
HDAC5 and HDAC9 in medulloblastoma: novel markers for risk
stratification and role in tumor cell growth. Clin Cancer Res.
16:3240–3252. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Moreno DA, Scrideli CA, Cortez MA, et al:
Differential expression of HDAC3, HDAC7 and HDAC9 is associated
with prognosis and survival in childhood acute lymphoblastic
leukaemia. Br J Haematol. 150:665–673. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Satterwhite E, Sonoki T, Willis TG, et al:
The BCL11 gene family: involvement of BCL11A in lymphoid
malignancies. Blood. 98:3413–3420. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kosari F, Asmann YW, Cheville JC and
Vasmatzis G: Cysteine-rich secretory protein-3: a potential
biomarker for prostate cancer. Cancer Epidemiol Biomarkers Prev.
11:1419–1426. 2002.PubMed/NCBI
|
|
22
|
Bjartell AS, Al-Ahmadie H, Serio AM, et
al: Association of cysteine-rich secretory protein 3 and
beta-microseminoprotein with outcome after radical prostatectomy.
Clin Cancer Res. 13:4130–4138. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mollenhauer J, Wiemann S, Scheurlen W, et
al: DMBT1, a new member of the SRCR superfamily, on chromosome
10q25.3–26.1 is deleted in malignant brain tumours. Nat Genet.
17:32–39. 1997.PubMed/NCBI
|
|
24
|
Mollenhauer J, Herbertz S, Holmskov U, et
al: DMBT1 encodes a protein involved in the immune defense and in
epithelial differentiation and is highly unstable in cancer. Cancer
Res. 60:1704–1710. 2000.PubMed/NCBI
|
|
25
|
Kim HS, Han HD, Armaiz-Pena GN, et al:
Functional roles of Src and Fgr in ovarian carcinoma. Clin Cancer
Res. 17:1713–1721. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yoo KH, Kim SK, Chung JH and Chang SG:
Nitric oxide synthase 2 gene polymorphisms are associated with
prostatic volume in Korean men with benign prostatic hyperplasia.
Asian J Androl. 12:690–696. 2010.PubMed/NCBI
|
|
27
|
Sung HJ, Ahn JM, Yoon YH, et al:
Identification and validation of SAA as a potential lung cancer
biomarker and its involvement in metastatic pathogenesis of lung
cancer. J Proteome Res. 10:1383–1395. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Urieli-Shoval S, Finci-Yeheskel Z, Dishon
S, et al: Expression of serum amyloid a in human ovarian epithelial
tumors: implication for a role in ovarian tumorigenesis. J
Histochem Cytochem. 58:1015–1023. 2010. View Article : Google Scholar : PubMed/NCBI
|
